Virginia Retirement System’s PDL BioPharma, Inc. PDLI Stock Holding History

Virginia Retirement System’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$174K	Buy	+52,400	New	+$163K	﹤0.01%	986

Other funds holding PDLI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virginia Retirement System's PDLI Position: Q1 2016 in Review

Virginia Retirement System opened a new position in PDL BioPharma, Inc. (PDLI) in Q1 2016: 52,400 shares worth $174K. The stake represents ﹤0.01% of the portfolio and ranks #986 among its holdings.

195 funds tracked by Wall St. Rank hold PDLI as of Q1 2016.

Virginia Retirement System held 52,400 shares of PDL BioPharma, Inc. worth $174K as of Q1 2016.
PDL BioPharma, Inc. was a new Virginia Retirement System position in Q1 2016.
PDL BioPharma, Inc. made up ﹤0.01% of Virginia Retirement System's portfolio in Q1 2016, its #986 holding.
195 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.